1932

Abstract

Prognostic variables such as the ejection fraction and peak oxygen consumption can be used to place patients with heart failure in risk strata. Some vasodilators have been shown to improve survival at all stages of heart failure with the probability of benefit increasing as the prognosis worsens. Quantitative estimates of survival among groups defined by prognostic variables and treatments should be used to make more informed benefit-to-risk assessments.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.45.1.341
1994-02-01
2024-06-12
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.45.1.341
Loading
/content/journals/10.1146/annurev.med.45.1.341
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error